HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Silva, D. G. Articles by Charlton, B. Search for Related Content PubMed PubMed Citation Articles by Silva, D. G. Articles by Charlton, B.

Mechanisms of Accelerated Immune-Mediated Diabetes Resulting from Islet Cell Expression of a Fas Ligand Transgene¹

Diego G. Silva^*,, Nikolai Petrovsky^2,*,,, Luis Socha^*,, Robyn Slattery, Paul Gatenby and Brett Charlton

^* Autoimmunity Research Unit, The Canberra Hospital, Medical School, Australian National University, Medical Informatics Center, University of Canberra, and The John Curtin School of Medical Research, Canberra, Australia

Nonobese diabetic (NOD) mice transgenic for Fas ligand (FasL) on islet cells (HIPFasL mice) exhibit an accelerated diabetes distinct from the normal autoimmune diabetes of NOD mice. This study was undertaken to define the mechanism underlying accelerated diabetes development in HIPFasL mice. It was found that diabetes in HIPFasL mice is dependent on the NOD genetic background, as HIPFasL does not cause diabetes when crossed into other mice strains and is lymphocyte dependent, as it does not develop in HIPFasL^SCID mice. Diabetes development in NOD^SCID recipients of diabetic HIPFasL splenocytes is slower than when using splenocytes from diabetic NOD mice. cells from HIPFasL mice are more susceptible to cytokine-induced apoptosis than wild-type NOD cells, and this can be blocked with anti-FasL Ab. HIPFasL islets are more rapidly destroyed than wild-type islets when transplanted into nondiabetic NOD mice. This confirms that FasL⁺ islets do not obtain immune privilege, and instead NOD cells constitutively expressing FasL are more susceptible to apoptosis induced by Fas-FasL interaction. These findings are consistent with the accelerated diabetes of young HIPFasL mice being a different disease process from the autoimmune diabetes of wild-type NOD mice. The data support a mechanism by which cytokines produced by the insulitis lesion mediate up-regulation of cell Fas expression, resulting in suicide or fratricide of HIPFasL cells that overexpress FasL.

This article has been cited by other articles:

				A. M. Gusdon, T. V. Votyakova, I. J. Reynolds, and C. E. Mathews Nuclear and Mitochondrial Interaction Involving mt-Nd2 Leads to Increased Mitochondrial Reactive Oxygen Species Production J. Biol. Chem., February 23, 2007; 282(8): 5171 - 5179. [Abstract] [Full Text] [PDF]

				J. A. Emamaullee and A.M. J. Shapiro Interventional Strategies to Prevent {beta}-Cell Apoptosis in Islet Transplantation. Diabetes, July 1, 2006; 55(7): 1907 - 1914. [Abstract] [Full Text] [PDF]

				J. B. Laoag-Fernandez, H. Matsuo, H. Murakoshi, A. L. Hamada, B. K. Tsang, and T. Maruo 3,5,3'-Triiodothyronine Down-Regulates Fas and Fas Ligand Expression and Suppresses Caspase-3 and Poly (Adenosine 5'-Diphosphate-Ribose) Polymerase Cleavage and Apoptosis in Early Placental Extravillous Trophoblasts in Vitro J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4069 - 4077. [Abstract] [Full Text] [PDF]

				P. Augstein, P. Heinke, E. Salzsieder, S. Berg, R. Rettig, C. Salzsieder, and L. C. Harrison Fas Ligand Down-Regulates Cytokine-Induced Fas Receptor Expression on Insulinoma (NIT-1), But Not Islet Cells, from Autoimmune Nonobese Diabetic Mice Endocrinology, June 1, 2004; 145(6): 2747 - 2752. [Abstract] [Full Text] [PDF]